CVS Health

Recent news

• Rating change
  Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $113
  Market Newswire · 2026/8/26
• Rating change
  Morgan Stanley Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $111
  Market Newswire · 2026/8/10
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Joyner J. David
  SEC · 2026/4/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Khichi Samrat S.
  SEC · 2026/4/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.
  SEC · 2026/5/16
• Rating change
  TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/8/26
• Rating change
  Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
  Market Newswire · 2026/9/16
• Rating change
  Bernstein Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $106
  Market Newswire · 2026/9/9
• Rating change
  Jefferies Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $120
  Market Newswire · 2026/8/31
• Argus Research Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $114
  Market Newswire · 2026/8/19
• Rating change
  A Quick Look at Today's Ratings for CVS Health(CVS.US), With a Forecast Between $107 to $126
  Market Newswire · 2026/8/7
• Jefferies Maintains CVS GROUP PLC(CVSGF.US) With Hold Rating, Raises Target Price to $18.55
  Market Newswire · 2026/9/25
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.
  SEC · 2026/5/16
• Barclays Maintains CVS GROUP PLC(CVSGF.US) With Buy Rating, Cuts Target Price to $21.16
  Market Newswire · 2026/9/29
• Rating change
  J.P. Morgan Remains a Buy on CVS Health (CVS)
  TipRanks · 2026/8/12
• UBS Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $118
  Market Newswire · 2026/9/3
• Company notice
  CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Balser Jeffrey R.
  SEC · 2026/5/16
• Rating change
  J.P. Morgan Maintains CVS Health(CVS.US) With Buy Rating, Announces Target Price $118
  Market Newswire · 2026/8/12
• Rating change
  BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $120
  Market Newswire · 2026/9/15
• Company Q&A | Andon Health: The company's test kit products are currently available through sales channels including Amazon, CVS, and Walmart.
  Gelonghui Finance · 2026/9/22
• Wells Fargo Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $123
  Market Newswire · 9/10

Headlines are aggregated automatically and are not independently verified or edited by our team.